AAAAAA

   
Results: 1-10 |
Results: 10
Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer
Authors: Buyse, M Thirion, P Carlson, RW Burzykowski, T Molenberghs, G Piedbois, P
Citation: M. Buyse et al., Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer, J NAT CANC, 93(5), 2001, pp. 399-400
Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer
Authors: Laudanski, J Niklinska, W Burzykowski, T Chyczewski, L Niklinski, J
Citation: J. Laudanski et al., Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer, EUR RESP J, 17(4), 2001, pp. 660-666
Validation of surrogate end points in multiple randomized clinical trials with failure time end points
Authors: Burzykowski, T Molenberghs, G
Citation: T. Burzykowski et G. Molenberghs, Validation of surrogate end points in multiple randomized clinical trials with failure time end points, J ROY STA C, 50, 2001, pp. 405-422
p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland
Authors: Niklinska, W Burzykowski, T Chyczewski, L Rusin, MR Furman, M Laudanski, J Chyczewska, E Sulik, M Niklinski, J
Citation: W. Niklinska et al., p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland, EUR J CAN P, 9(2), 2000, pp. 81-87
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
Authors: Buyse, M Thirion, P Carlson, RW Burzykowski, T Molenberghs, G Piedbois, P
Citation: M. Buyse et al., Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis, LANCET, 356(9227), 2000, pp. 373-378
Criteria for the validation of surrogate endpoints in randomized experiments (vol 54, pg 1014, 1998)
Authors: Buyse, M Molenberghs, G Burzykowski, T
Citation: M. Buyse et al., Criteria for the validation of surrogate endpoints in randomized experiments (vol 54, pg 1014, 1998), BIOMETRICS, 56(1), 2000, pp. 324-325
Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial
Authors: Ceremuzynski, L Budaj, A Czepiel, A Burzykowski, T Achremczyk, P Smielak-Korombel, W Maciejewicz, J Dziubinska, J Nartowicz, E Kawka-Urbanek, T Piotrowski, W Hanzlik, J Cieslinski, A Kawecka-Jaszcz, K Gessek, J Wrabec, K
Citation: L. Ceremuzynski et al., Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial, CARDIO DRUG, 13(3), 1999, pp. 191-200
Analysis of incomplete public health data
Authors: Molenberghs, G Burzykowski, T Michiels, B Kenward, MG
Citation: G. Molenberghs et al., Analysis of incomplete public health data, REV EPIDEM, 47(6), 1999, pp. 499-514
Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer
Authors: Niklinski, J Burzykowski, T Niklinska, W Laudanski, J Chyczewski, L Rapellino, M Furman, M
Citation: J. Niklinski et al., Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer, EUR RESP J, 12(6), 1998, pp. 1424-1428
Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer
Authors: Laudanski, J Burzykowski, T Niklinska, W Chyczewski, L Furman, M Niklinski, J
Citation: J. Laudanski et al., Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer, LUNG CANC, 22(3), 1998, pp. 191-200
Risultati: 1-10 |